| Authors: |
Burton RL; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Kim HW; Department of Pediatrics, Ewha Womans University College of Medicine, Seoul, Republic of Korea; Center for Vaccine Evaluation and Study, Ewha Womans University College of Medicine, Seoul, Republic of Korea., Lee S; Department of Pediatrics, Ewha Womans University College of Medicine, Seoul, Republic of Korea; Center for Vaccine Evaluation and Study, Ewha Womans University College of Medicine, Seoul, Republic of Korea., Kim H; Bio R&D Center, SK bioscience, Seongnam-Si, Gyeonggi-do, Republic of Korea., Seok JH; Bio R&D Center, SK bioscience, Seongnam-Si, Gyeonggi-do, Republic of Korea., Ku KY; Department of Biopharmaceuticals R&D, LG Chem, Seoul, Republic of Korea., Seo J; Department of Biopharmaceuticals R&D, LG Chem, Seoul, Republic of Korea., Kim SJ; Department of Biopharmaceuticals R&D, LG Chem, Seoul, Republic of Korea., Xie J; Infectious Diseases/Vaccines, Merck & Co., Inc., Kenilworth, NJ, USA., McGuinness D; Infectious Diseases/Vaccines, Merck & Co., Inc., Kenilworth, NJ, USA., Skinner JM; Infectious Diseases/Vaccines, Merck & Co., Inc., Kenilworth, NJ, USA., Choi SK; EuBiologics Co., Ltd, Chuncheon, Republic of Korea., Baik YO; EuBiologics Co., Ltd, Chuncheon, Republic of Korea., Bae S; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Nahm MH; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Kim KH; Department of Pediatrics, Ewha Womans University College of Medicine, Seoul, Republic of Korea; Center for Vaccine Evaluation and Study, Ewha Womans University College of Medicine, Seoul, Republic of Korea. Electronic address: kaykim@ewha.ac.kr. |